ASH 2023: Analyzing IsKia Trial

The IsKia trial findings presented at ASH 2023 are highlighted by Dr Fonseca.

Related Keywords

,Conference Perspectives ,Multiple Myeloma ,Analyzing Iskia ,American Society Of Hematology ,Cash ,Newly Diagnosed Multiple Myeloma ,Triplet Therapy ,Quadruplet Therapy ,Perseus Trial ,Daratumumab ,Bortezomib ,Lenalidomide ,Dexamethasone ,Mvrd ,